PI4Kbeta/PKG-IN-1 (Compound 19) is an orally active dual inhibitor targeting Plasmodium phosphatidylinositol 4-kinase beta (PI4Kbeta) and cGMP-dependent protein kinase (PKG). PI4Kbeta/PKG-IN-1 exhibits potent antiplasmodial activity. PI4Kbeta/PKG-IN-1 is promising for research of malaria[1].
Molecular Weight:
409.80
Formula:
C19H13ClFN7O
Target:
Parasite,PI4K,PKG
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
